• Newsletters
  • Gift Membership
Logo Logo
Take Scroll With You Download the app to read our award-winning journalism on the go and stay up-to-date with our notifications.
Get the app Get the app
ANDROID iOS
  • Home
  • Common Ground
  • The India Fix
  • Eco India
  • The Latest
  • The Reel
  • Magazine
  • Video
  • Trending
    • Why are Bangladeshis turning against India?
    • Short stories from Nagaland: A young man’s maiden visit to a clothing showroom doesn’t go as planned
    • A hidden debt crisis is silently wrecking the dreams of India’s middle class
    • Why Estonian writer Jaan Kross’s historical fiction is worth reading in India today
    • The first woman who climbed to the top of the world – and vanished
    • ‘I am still writing for the lonely soul’: At 91, Ruskin Bond looks back at his literary life
    • Readers’ comments: As inheritors of the sanatan dharma, how can we foster a questioning people?
    • Crisis posed by AI is a moment to rethink education – with help from Hannah Arendt
    • ‘An emotional drama within the world of crime’: Mani Ratnam on ‘Thug Life’
    • Food habits that work as well as weight-loss drugs
    • How India could cut its reliance on China for rare earth minerals
    • Watch: Why workers at an Adani power plant in Jharkhand went on a strike
  • Sections
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Science and Technology
    • In Pictures
    • Announcements
    • Bookshop
    • The Field
    • Pulse
    • Elections 2024

DCGI

  • Drug regulators stop production at 18 firms in drive against spurious medicines

    Drug regulators stop production at 18 firms in drive against spurious medicines

    Scroll Staff
    · Mar 28, 2023 · 08:26 pm
  • Tamil Nadu drug controller suspends production at Global Pharma after CDC alert

    Tamil Nadu drug controller suspends production at Global Pharma after CDC alert

    Tabassum Barnagarwala
    · Feb 04, 2023 · 05:34 pm
  • Indian firm recalls eye drops after US flags 55 cases of adverse events, including one death

    Indian firm recalls eye drops after US flags 55 cases of adverse events, including one death

    Tabassum Barnagarwala
    · Feb 03, 2023 · 06:42 pm
  • India’s drug approval system is broken but a proposed new law does nothing to fix it

    India’s drug approval system is broken but a proposed new law does nothing to fix it

    Dinesh Thakur Prashant Reddy T
    · Aug 06, 2022 · 09:00 am
  • Serum Institute of India applies for full market authorisation of Covishield vaccine

    Serum Institute of India applies for full market authorisation of Covishield vaccine

    Scroll Staff
    · Dec 31, 2021 · 06:47 pm
  • Covaxin receives DCGI approval for use in children from 12 to 18 years

    Covaxin receives DCGI approval for use in children from 12 to 18 years

    Scroll Staff
    · Dec 26, 2021 · 08:15 am
  • Covid-19: Biological E gets DCGI approval to conduct phase 2, 3 vaccine trials on children

    Covid-19: Biological E gets DCGI approval to conduct phase 2, 3 vaccine trials on children

    Scroll Staff
    · Sep 03, 2021 · 09:34 pm
  • Coronavirus: Bharat Biotech vaccine approved in clinical trial mode, clarifies ICMR

    Coronavirus: Bharat Biotech vaccine approved in clinical trial mode, clarifies ICMR

    Scroll Staff
    · Jan 06, 2021 · 11:01 am
  • Coronavirus: Congress questions Covaxin’s approval before completing phase-3 trials

    Coronavirus: Congress questions Covaxin’s approval before completing phase-3 trials

    Scroll Staff
    · Jan 03, 2021 · 03:09 pm
  • Coronavirus: Serum Institute gets drugs regulator approval to resume India trials of Oxford vaccine

    Coronavirus: Serum Institute gets drugs regulator approval to resume India trials of Oxford vaccine

    Scroll Staff
    · Sep 16, 2020 · 10:35 am